MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer

被引：16
作者：
Li, Yike [1 ,2 ,3 ]
Tian, Wanjia [1 ,3 ]
Zhang, Hong [2 ]
Zhang, Zhijian [2 ]
Zhao, Qinghe [1 ]
Chang, Lei [1 ]
Lei, Ningjing [2 ]
Zhang, Weiwei [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Gynecol, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Acad Med Sci, Zhengzhou, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
mesothelin; ovarian cancer; prognostic biomarker; chemoresistance; bioinformatics analysis; MESOTHELIN; EXPRESSION; CELLS; PROLIFERATION; IMMUNOTHERAPY; CHEMOTHERAPY; BEVACIZUMAB; CHECKPOINT; ANTITUMOR; PATTERNS;
D O I：
10.3389/fonc.2022.830570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Mesothelin (MSLN) is a glycoprotein with various expression degrees in different tumors including mesothelioma, ovarian cancer, pancreatic cancer, etc. MSLN is considered to play an important role in cell survival, proliferation, and tumor progression. Although the expression of MSLN in tumors makes it a potential therapeutic target, its mechanism of action is still unclear, especially its correlation with immune cells infiltration in the tumor microenvironment has not been investigated. In this study, we detected the overexpression of MSLN in ovarian cancer using database analysis and tissue-array staining. We further evaluated the diagnostic value of MSLN and found it was associated with poor overall survival in ovarian cancer. In addition, the high expression of MSLN was significantly related to the immune-related genes and chemoresistant genes. We confirmed the overexpression of MSLN in the chemoresistant ovarian cancer cell lines. Our research suggests that MSLN participates in a variety of pathways related to the suppression of immune activation and promotion of chemoresistance, leading to a poor prognosis in ovarian cancer.
引用
收藏
页数：13
相关论文
共 54 条
[1]   Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases [J].
Avula, Leela Rani ;
Rudloff, Michael ;
El-Behaedi, Salma ;
Arons, Danielle ;
Albalawy, Rakan ;
Chen, Xiongfong ;
Zhang, Xianyu ;
Alewine, Christine .
MOLECULAR CANCER RESEARCH, 2020, 18 (02) :229-239
[2]   Mesothelin is not required for normal mouse development or reproduction [J].
Bera, TK ;
Pastan, I .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (08) :2902-2906
[3]   Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression [J].
Bharadwaj, Uddalak ;
Marin-Muller, Christian ;
Li, Min ;
Chen, Changyi ;
Yao, Qizhi .
MOLECULAR CANCER, 2011, 10
[4]   Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Tosolini, Marie ;
Kirilovsky, Amos ;
Waldner, Maximilian ;
Obenauf, Anna C. ;
Angell, Helen ;
Fredriksen, Tessa ;
Lafontaine, Lucie ;
Berger, Anne ;
Bruneval, Patrick ;
Fridman, Wolf Herman ;
Becker, Christoph ;
Pages, Franck ;
Speicher, Michael R. ;
Trajanoski, Zlatko ;
Galon, Jerome .
IMMUNITY, 2013, 39 (04) :782-795
[5]   Anti-Mesothelin CAR T cell therapy for malignant mesothelioma [J].
Castelletti, Laura ;
Yeo, Dannel ;
van Zandwijk, Nico ;
Rasko, John E. J. .
BIOMARKER RESEARCH, 2021, 9 (01)
[6]   High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma [J].
Cheng, W-F ;
Huang, C-Y ;
Chang, M-C ;
Hu, Y-H ;
Chiang, Y-C ;
Chen, Y-L ;
Hsieh, C-Y ;
Chen, C-A .
BRITISH JOURNAL OF CANCER, 2009, 100 (07) :1144-1153
[7]   Acquired chemotherapy resistance in ovarian cancer [J].
Christie, E. L. ;
Bowtell, D. D. L. .
ANNALS OF ONCOLOGY, 2017, 28 :13-15
[8]   Current Perspectives in Cancer Immunotherapy [J].
Christofi, Theodoulakis ;
Baritaki, Stavroula ;
Falzone, Luca ;
Libra, Massimo ;
Zaravinos, Apostolos .
CANCERS, 2019, 11 (10)
[9]   Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation [J].
Coelho, Ricardo ;
Ricardo, Sara ;
Amaral, Ana Luisa ;
Huang, Yen-Lin ;
Nunes, Mariana ;
Neves, Jose Pedro ;
Mendes, Nuno ;
Lopez, Monica Nunez ;
Bartosch, Carla ;
Ferreira, Veronica ;
Portugal, Raquel ;
Lopes, Jose Manuel ;
Almeida, Raquel ;
Heinzelmann-Schwarz, Viola ;
Jacob, Francis ;
David, Leonor .
ONCOGENESIS, 2020, 9 (06)
[10]   Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment [J].
Coelho, Ricardo ;
Marcos-Silva, Lara ;
Ricardo, Sara ;
Ponte, Filipa ;
Costa, Antonia ;
Lopes, Jose Manuel ;
David, Leonor .
EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (02) :177-186
123456